#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    C3 glomerulopathy Adrenogenital syndrome Ductal adenocarcinoma of pancreas Lymphoma HER2 gene amplification Malignant neoplasm of choroid ABO haemolytic disease of newborn Adenoid cystic carcinoma Hodgkin's disease recurrent Cerebellar ataxia Microvillous inclusion disease Epstein-Barr virus infection Breast angiosarcoma metastatic Metachromatic leukodystrophy Cystic fibrosis respiratory infection suppression More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage II – Basic Information Thrombotic thrombocytopenic purpura – Treatment Turner’s syndrome – Diagnostics Glycogen storage disease type V Haemophilia B with anti factor IX Inclusion body myositis – Treatment Paraneoplastic neurological syndrome – Diagnostics Crigler-Najjar syndrome – Basic Information Marginal zone lymphoma Inclusion body myositis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Emapalumab Axatilimab SODIUM SELENITE PENTAHYDRATE INF904 Bromocriptine Betula Verrucosa Pollen D-Camphor Tin816 D,L-Lysine Acetylsalicylate Elasomeran TIL CELLS Dordaviprone ASP2957 USNOFLAST Ifezuntirgene Inilparvovec Tenofovir Alafenamide Galcanezumab NALOXEGOL GSKVX000000017986 Betaine Citrate More therapies…

    Learn about Your Condition

    Pituitary tumour benign Ocular hypertension Breast cancer metastatic Ovarian cancer Peripheral artery thrombosis Skin neoplasm excision Haemodialysis Neurodegenerative disorder Sarcoma Meniere's disease Body mass index increased Gastrointestinal carcinoma Neurofibrosarcoma Laparotomy Upper limb fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myocardial infarction

  • Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Icosapent Ethyl
    • Tiemonium Methylsulphate
    • Empagliflozin
    Austria Germany Poland

  • Study Comparing Aspirin Alone to Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Fondaparinux Sodium
    • Acetylsalicylic Acid
    Denmark

  • Study on the Safety of Ticagrelor and Aspirin in Patients with ST-Elevation Myocardial Infarction After Heart Procedure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Acetylsalicylic Acid
    The Netherlands

  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac ventricular thrombosis
    • Acute myocardial infarction
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Perflutren
    • Apixaban
    Denmark Sweden

  • Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    • Acute myocardial infarction
    Investigated Drugs:
    • Noradrenaline Tartrate
    Belgium Czechia Denmark Germany Greece The Netherlands +3

  • Study on the Effects of Ramipril, Bisoprolol, and Dapagliflozin in Patients with ST-Elevation Myocardial Infarction (Heart Attack)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Ramipril
    • Bisoprolol
    • Dapagliflozin
    Sweden
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!